Content area
Bio-Techne Corp (TECH) - Financial Analysis Review
Bio-Techne Corp (Bio-Techne) manufactures, develops and markets biotechnology products and scientific tools. The company’s products include ELISA kits, ELISpot kits, enzymes, Luminex assays, proteins, GMP products and instruments. Its custom service offerings comprise antibody services, targeted protein degradation services, licensing, cell and gene therapy services, compound library services, ELISA services and gene engineering services.
GlobalData's Bio-Techne Corp (TECH) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
Bio-Techne Corp Key Recent Developments:
Apr 15,2025: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
Mar 24,2025: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
Mar 10,2025: Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
Mar 03,2025: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.